| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |